Literature DB >> 25747005

A novel large deletion in the RYR1 gene in a Belgian family with late-onset and recessive core myopathy.

Gauthier Remiche1, Hazim Kadhim2, Marc Abramowicz3, Nicolas Mavroudakis1, Nicole Monnier4, Joël Lunardi4.   

Abstract

We report a novel and particularly unusual type of mutation, namely, large deletion in the RYR1 gene, in a Belgian family with myopathy: Patients were found to be compound heterozygous and presented a clinico-pathological phenotype characterized by late-onset and recessive myopathy with cores. We depict the clinical, electrophysiological, pathological and molecular genetic characteristics of family members. To date, large deletions in the RYR1 gene have been reported in only two cases. Both involved different mutations and, in sharp contrast to our cases, presented with a very early-onset, neonatal, and a very severe or lethal phenotype. Overview of reported clinico-pathologic phenotypes, also highlights the rarity of combined late-onset/recessive co-occurrence in this group of myopathies with cores. Finally, this report underlines the broadening spectrum in this group of myopathologic disorders and highlights the concept of 'RYR1-associated/related core myopathies'.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Central core disease; Core myopathy; Deletion; Mutation; Pathology; RYR1 gene

Mesh:

Substances:

Year:  2015        PMID: 25747005     DOI: 10.1016/j.nmd.2015.01.016

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  2 in total

1.  Clinical Observation: Effect of a Second Transpositioned Variant in a Family with Autosomal Dominant Ryanodine Receptor-1-Related Disease.

Authors:  Tomer Avnon; Ran Svirsky; Avi Orr-Urtreger; Liora Sagie; Aviva Fattal-Valevski; Yakov Fellig; Shay Ben-Shachar
Journal:  J Pediatr Genet       Date:  2019-10-21

Review 2.  Update on Congenital Myopathies in Adulthood.

Authors:  George Konstantinos Papadimas; Sophia Xirou; Evangelia Kararizou; Constantinos Papadopoulos
Journal:  Int J Mol Sci       Date:  2020-05-24       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.